ESAR Home
![]()
Project information
![]()
![]()
Description
![]()
![]()
Participating institutions
![]()
![]()
Definition alert organisms
![]()
Results (summary)
![]()
Hypothesis
![]()
Data reported
![]()
![]()
Number of Specimen
![]()
![]()
Demographic Data
![]()
![]()
Operation
![]()
![]()
Patient location
![]()
![]()
Disciplines
![]()
![]()
Level of care
![]()
![]()
Causative for infection?
![]()
![]()
Organisms isolated
![]()
![]()
Material
![]()
![]()
Infections
![]()
![]()
![]()
Details
![]()
![]()
Antibiotic therapy
![]()
![]()
![]()
Details
![]()
![]()
Underlying Diseases
![]()
![]()
![]()
Details
![]()
![]()
Risk factors
![]()
![]()
![]()
Details
![]()
Global Results
![]()
![]()
Rates by specimen
![]()
![]()
![]()
1999
![]()
![]()
![]()
2000
![]()
![]()
![]()
Total
![]()
![]()
Rates by Phenotype
![]()
![]()
![]()
1999
![]()
![]()
![]()
2000
![]()
![]()
![]()
Total
![]()
![]()
Locations by specimen
![]()
![]()
![]()
Detail
Enterobacteriaceae
![]()
![]()
Level of care by specimen
![]()
![]()
![]()
Detail
Enterobacteriaceae
![]()
![]()
Disciplines
![]()
![]()
![]()
Detail
Enterobacteriaceae
![]()
![]()
![]()
+ Level
of care
![]()
![]()
Causative for infection?
![]()
![]()
![]()
Detail
Enterobacteriaceae
![]()
Results by Specimen
![]()
![]()
Beta-hemolytic streptoccci
![]()
![]()
![]()
Resistance (quarterly)
![]()
![]()
![]()
![]()
Macrolides
![]()
![]()
![]()
![]()
Glycopeptides
![]()
![]()
![]()
![]()
Penicillin
![]()
![]()
![]()
Disciplines
![]()
![]()
![]()
Infections
![]()
![]()
Pneumococci
![]()
![]()
![]()
Resistance (quarterly)
![]()
![]()
![]()
![]()
Macrolides
![]()
![]()
![]()
![]()
Glycopeptides
![]()
![]()
![]()
![]()
High level Penicillin
![]()
![]()
![]()
![]()
Low level Penicillin
![]()
![]()
![]()
Disciplines
![]()
![]()
![]()
Infections
![]()
![]()
Enterococci
![]()
![]()
![]()
Resistance (quarterly)
![]()
![]()
![]()
![]()
BL positive
![]()
![]()
![]()
![]()
Glycopeptides
![]()
![]()
![]()
![]()
High Level AMG
![]()
![]()
![]()
Disciplines
![]()
![]()
![]()
Infections
![]()
![]()
Haemophilus
![]()
![]()
![]()
Resistance (quarterly)
![]()
![]()
![]()
![]()
BL positive
![]()
![]()
![]()
![]()
Cephalosporins
![]()
![]()
![]()
![]()
Quinolones
![]()
![]()
![]()
Disciplines
![]()
![]()
![]()
Infections
![]()
![]()
Enterobacteriaceae
![]()
![]()
![]()
Resistance (quarterly)
![]()
![]()
![]()
![]()
Carbapenems
![]()
![]()
![]()
![]()
Quinolones
![]()
![]()
![]()
![]()
ESBL
![]()
![]()
![]()
![]()
Gentamicin
![]()
![]()
![]()
Disciplines
![]()
![]()
![]()
Infections
![]()
![]()
Acinetobacter
![]()
![]()
![]()
Resistance (quarterly)
![]()
![]()
![]()
![]()
Carbapenems
![]()
![]()
![]()
![]()
Gentamicin
![]()
![]()
![]()
Disciplines
![]()
![]()
![]()
Infections
![]()
![]()
Staphylococcus aureaus
![]()
![]()
![]()
Resistance (quarterly)
![]()
![]()
![]()
![]()
Total MRSA
![]()
![]()
![]()
![]()
MRSA + Teicoplanin
![]()
![]()
![]()
![]()
MRSA + Vancomycin
![]()
![]()
![]()
Disciplines
![]()
![]()
![]()
Infections
![]()
![]()
Cholera
![]()
![]()
Campylobacter
![]()
![]()
![]()
Resistance (quarterly)
![]()
![]()
![]()
![]()
Ciprofloxacin
![]()
![]()
![]()
Disciplines
![]()
![]()
![]()
Infections
![]()
![]()
Shigella
![]()
![]()
Salmonella
![]()
![]()
![]()
Resistance (quarterly)
![]()
![]()
![]()
![]()
Ciprofloxacin
![]()
![]()
![]()
Disciplines
![]()
![]()
![]()
Infections
![]()
![]()
Neisseria meningitidis
![]()
![]()
![]()
Resistance (quarterly)
![]()
![]()
![]()
![]()
Penicillin
![]()
![]()
![]()
Infections
![]()
![]()
Neisseria gonorrhoea
![]()
![]()
![]()
Resistance (quarterly)
![]()
![]()
![]()
![]()
BL positive
![]()
![]()
![]()
![]()
Quinolones
![]()
![]()
![]()
Infections
![]()
![]()
Anaerobes
![]()
![]()
![]()
Resistance (quarterly)
![]()
![]()
![]()
![]()
Co-Amoxiclav
![]()
![]()
![]()
![]()
Carbapenems
![]()
![]()
![]()
![]()
Metronidazole
![]()
![]()
![]()
Disciplines
![]()
![]()
![]()
Infections
![]()
![]()
Coag. neg. Staphylococci
![]()
![]()
![]()
Resistance (quarterly)
![]()
![]()
![]()
![]()
Teicoplanin
![]()
![]()
![]()
![]()
Vancomycin
![]()
![]()
![]()
Disciplines
![]()
![]()
![]()
Infections
![]()
![]()
Pseudomonas aeruginosa
![]()
![]()
![]()
Resistance (quarterly)
![]()
![]()
![]()
![]()
Cephalosporins
![]()
![]()
![]()
![]()
Gentamicin
![]()
![]()
![]()
![]()
Pip/Tazo
![]()
![]()
![]()
Disciplines
![]()
![]()
![]()
Infections
![]()
Results by Infection
![]()
![]()
Evaluable isolates
![]()
![]()
Infections & Outcome
![]()
![]()
Urinary tract
![]()
![]()
![]()
Causative
for infection?
![]()
![]()
![]()
Discipline
& level of care
![]()
![]()
![]()
Therapy
![]()
![]()
Respiratory tract
![]()
![]()
![]()
Causative
for infection?
![]()
![]()
![]()
Discipline
& level of care
![]()
![]()
![]()
Therapy
![]()
![]()
Wound
![]()
![]()
![]()
Causative
for infection?
![]()
![]()
![]()
Discipline
& level of care
![]()
![]()
![]()
Therapy
![]()
![]()
Skin & soft tissue
![]()
![]()
![]()
Causative
for infection?
![]()
![]()
![]()
Discipline
& level of care
![]()
![]()
![]()
Therapy
![]()
Other
ESBiC pages
![]()
![]()
ESBiC
Home
![]()
![]()
Structure
and Organisation
![]()
![]()
ESIC
![]()
![]()
ESIT
![]()
Links to other sites
![]()
Contact to ESBiC